Invitrogen™ Human Factor XI Native Protein

Réf. : BL-RE-177383Réf. fabricant : RP43075 50 μg
267,00 € HT

RP-43075 contains native human Factor XI protein. RP-43075 may be used as a positive control in many immunological assays. The product is of human blood/plasma origin. Although the starting material was tested prior to initiation of the…

Numéro d’adhésion
P03951
Concentration
7.0 mg/mL
À utiliser avec (application)
Control
Formule
50% water with 50% glycerol and no preservative
Identification génétique (Entrez)
2160
Marque
Invitrogen

RP-43075 contains native human Factor XI protein. RP-43075 may be used as a positive control in many immunological assays. The product is of human blood/plasma origin. Although the starting material was tested prior to initiation of the…

RP-43075 contains native human Factor XI protein. RP-43075 may be used as a positive control in many immunological assays. The product is of human blood/plasma origin. Although the starting material was tested prior to initiation of the manufacturing process, and was found negative or nonreactive for anti-HIV-1/2, HIV-1 antigen(s), HBsAg, STS, anti-HCV, anti-HBcore and anti-HTLV I & II, extreme caution should be used when handling this material as there is a margin of error in all tests. This product is to be used for IN VITRO research purposes only, and is not intended for clinical or diagnostic use!

This gene encodes coagulation factor XI of the blood coagulation cascade. This protein is present in plasma as a zymogen, which is a unique plasma coagulation enzyme because it exists as a homodimer consisting of two identical polypeptide chains linked by disulfide bonds. During activation of the plasma factor XI, an internal peptide bond is cleaved by factor XIIa (or XII) in each of the two chains, resulting in activated factor XIa, a serine protease composed of two heavy and two light chains held together by disulfide bonds. This activated plasma factor XI triggers the middle phase of the intrisic pathway of blood coagulation by activating factor IX. Defects in this factor lead to Rosenthal syndrome, a blood coagulation abnormality.

Espèces

Espèces : Humaine.

Conjugué

Conjugué : Unconjugated.

Conservation

Conservation : -20°C, Avoid Freeze/Thaw Cycles.

Formulation

Concentration : 7,0 mg/mL.

Statut réglementaire

Réservé à la recherche (RUO).

Caractéristiques techniques

Général
MarqueInvitrogen
Réf. fournisseur (Fisher Scientific)11564111
Caractéristiques
Numéro d’adhésionP03951
Concentration7.0 mg/mL
À utiliser avec (application)Control
Formule50% water with 50% glycerol and no preservative
Identification génétique (Entrez)2160
NomHuman Factor XI
Quantité50 μg
SourceHuman
État réglementaireRUO
Alias de gène1600027G01Rik; AI503996; Cf11; Coagulation factor XI; Coagulation factor XIa heavy chain; Coagulation factor XIa light chain; F11; FXI; LRRGT00086; plasma thromboplastin antecedent; PTA
Nom usuelFactor XI
Symbole de gène(s)F11
Activité biologiqueSpecific Activity =372 U/mg; determined by Factor XI clotting assay where 1 U equals the Factor XI activity in 1 mL of normal human plasma.
ConjuguéUnconjugated
EspècesHuman
FormeLiquid
Sous-type de protéineNative
Caractéristiques physiques
Poids moléculaire160 kDa
Stockage et expédition
Contenu et stockage-20°C, Avoid Freeze/Thaw Cycles

Origine et douane

Réf. fabricantRP43075
Pays d’origineÉtats-Unis
Code douanier (SH)3002 15 00 00
Une question, une configuration particulière ?
Contactez-nous pour un devis.